CD4 and neoplasm: CD4+ T cells redirected to recognize HLA‐I‐restricted antigens with optimal TCRs can respond to low peptide densities, making them attractive for immunotherapy, as tumour‐associated peptides are usually present at the cell surface at very low copy numbers of fewer than 50 copies per cell (47 and unpublished).